We are live on
!
Find out more
BioNTech
BNTX
BNTX
284 hedge funds and large institutions have $4.56B invested in BioNTech in 2025 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 85 increasing their positions, 75 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
91% more first-time investments, than exits
New positions opened: 67 | Existing positions closed: 35
13% more repeat investments, than reductions
Existing positions increased: 85 | Existing positions reduced: 75
12% more funds holding
Funds holding: 254 → 284 (+30)
0.27% more ownership
Funds ownership: 21% → 21.27% (+0.27%)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
3% less call options, than puts
Call options by funds: $138M | Put options by funds: $142M
8% less capital invested
Capital invested by funds: $4.97B → $4.56B (-$415M)
Holders
284
Holders Change
+30
Holders Change %
+11.81%
% of All Funds
3.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
67
Increased
85
Reduced
75
Closed
35
Calls
$138M
Puts
$142M
Net Calls
-$4.07M
Net Calls Change
+$41.8M
Top Buyers
| 1 |
Jane Street
New York
|
+$117M |
| 2 |
D.E. Shaw & Co
New York
|
+$49.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$48.4M |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$47.8M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
+$44.1M |
Top Sellers
| 1 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$668M |
| 2 |
P
Pfizer
New York
|
-$164M |
| 3 |
Bank of New York Mellon
New York
|
-$45.8M |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$36.9M |
| 5 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$35.2M |
